DCGen
Seoul
About DCGen
The company provides a breast cancer prognosis prediction kit that enables the analysis of breast cancer-specific somatic mutation genes. This kit assists in the selection of effective treatments and enhances physicians' expertise in clinical practice and cancer research. DCGen is a company that offers a cutting-edge multigene assay kit designed for biotechnology management purposes. DCGen aims to empower doctors, patients, and their families to make informed medical decisions through the utilization of genomic analysis technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Dec 2019)
- Website: dcgen.co.kr
- Phone: 02-3675-7885
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/dcgen-3250782 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.